Calypso Biotech BV has entered into an agreement to be acquired by Novartis AG, which will pay. Calypsos US$250m upfront upon closing plus of up to US$175.
Tag Archive for: Calypso Biotech BV
Calypso Biotech BV has entered into an agreement to be acquired by Novartis AG, which will pay. Calypsos US$250m upfront upon closing plus of up to US$175.